4D Molecular Therapeutics Inc (FDMT) — Long-term Investment Intensity
4D Molecular Therapeutics Inc (FDMT) has a Long-term Investment Intensity of 19.7% as of December 2025. Long-term investments of $111.38 Million represent 19.7% of total assets of $566.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of 4D Molecular Therapeutics Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
4D Molecular Therapeutics Inc Long-term Investment Intensity (2021–2025)
This chart shows how 4D Molecular Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 19.7%, reflecting long-term investments of $111.38 Million against total assets of $566.71 Million USD. Also explore FDMT current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for 4D Molecular Therapeutics Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for 4D Molecular Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 4D Molecular Therapeutics Inc (FDMT) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 19.7% | $111.38 Million | $566.71 Million | ▲ +5.3 pp |
| 2024 | 14.4% | $80.58 Million | $560.38 Million | ▲ +11.2 pp |
| 2023 | 3.2% | $10.95 Million | $339.89 Million | ▲ +1.3 pp |
| 2022 | 1.9% | $4.91 Million | $261.85 Million | ▼ -17.3 pp |
| 2021 | 19.1% | $67.65 Million | $353.49 Million | — |